Development of a point-of-care microfluidic device for Therapeutic Drug Monitoring in cancer treatment (POC-TDM)

Project Information

POC-TDM

Grant agreement ID: 101065044

DOI 10.3030/101065044

EC signature date 7 June 2022

Start date 1 September 2022

End date 31 August 2024

Funded under

• Marie Skłodowska-Curie Actions (MSCA)

Total cost € 0,00

EU contribution € 157 622,40

Coordinated by

HUN-REN ENERGIATUDOMANYI KUTATOKOZPONT
Hungary

Publications

Peer reviewed articles (2)

Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells

Author(s): K. Szebenyi, A. Furedi, E. Bajtai, S. N. Sama, A. Csiszar, B. Gombos, P. Szabo, M. Grusch, G. Szakacs
Published in: Drug Resistance Updates, 2023, ISSN 1368-7646
Publisher: Churchill Livingstone
DOI: 10.1016/j.drup.2023.101007

Positive Impulsive Control of Tumor Therapy—A Cyber-Medical Approach

Author(s): L. Kovacs, T. Ferenci, B. Gombos, A. Furedi
Published in: IEEE Transactions on Systems, Man, and Cybernetics: Systems, 2023, ISSN 2168-2232
Publisher: IEEE Xplore
DOI: 10.1109/TSMC.2023.3315637